Skip to main content
FDA clears plasmapheresis system from Haemonetics

The FDA has granted Haemonetics 510(k) clearance for its NexSys PCS plasmapheresis system, intended for blood plasma collection. The system, which features bi-directional connectivity to the company's NexLynk DMS donor management system, enables automated end-of-procedure documentation and automated collection-procedure programming.

Full Story: